OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 16

Showing 16 citing articles:

Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer
Josephine B. Oehler, Weranga Rajapaksha, Hugo Albrecht
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 723-723
Open Access | Times Cited: 18

Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 8

Pectin from fruit peel: A comprehensive review on various extraction approaches and their potential applications in pharmaceutical and food industries
Savita Dixit, L. Muruganandam, I. Ganesh Moorthy
Carbohydrate Polymer Technologies and Applications (2025), pp. 100708-100708
Open Access | Times Cited: 1

From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
Fatemah Basingab, Omniah A. Alshahrani, Ibtehal AlAnsari, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 27-51
Open Access

Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity
Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, Simone Giovannuzzi, et al.
International Journal of Biological Macromolecules (2025), pp. 140462-140462
Closed Access

Eco-Friendly Nanotherapeutics: Metallic Nanoparticles for Targeting Breast Cancer
Darakhshan Javaid, Shahid Yousuf Ganie, Syed Sanober Qadri, et al.
European Journal of Pharmacology (2025), pp. 177603-177603
Closed Access

Nanostructured materials for breast cancer therapeutics enhancing drug delivery through nanofibers, nano-mesh, and nanoflowers
Navya Aggarwal, Shreya Gupta, Shinjini Sen, et al.
Next Nanotechnology (2025) Vol. 8, pp. 100159-100159
Open Access

Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions
Md Abdus Samad, Iftikhar Ahmad, Torki A. Zughaibi, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100268-100268
Open Access

αvβ3 integrin aptamer functionalized pH-responsive lipid polymer hybrid nanoparticles for targeted co-delivery of paclitaxel and tamoxifen
Mahavir Narwade, Niladri Haldar, Rajkumar Samanta, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141754-141754
Closed Access

New developments in the nanocarrier-based drug delivery system for the treatment of breast cancer
Rashid Al‐Yahyai, Jamilah Al Kalbani
Asia-Pacific Journal of Pharmacotherapy & Toxicology (2025), pp. 33-43
Closed Access

Nanoparticle Albumin-Bound Bortezomib: Enhanced Antitumor Efficacy and Tumor Accumulation in Breast Cancer Therapy
Anita Saremi Poor, Bagher Davaeil, Mahnaz Ramezanpour, et al.
Molecular Pharmaceutics (2025)
Closed Access

Precision arrows: Navigating breast cancer with nanotechnology siRNA
Nandani Jayaswal, Shriyansh Srivastava, Sachin Kumar, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124403-124403
Closed Access | Times Cited: 3

Synthesis, characterization, and applications of starch-based nano drug delivery systems for breast cancer therapy: A review
Shijuan Mei, R. Roopashree, Farag M. A. Altalbawy, et al.
International Journal of Biological Macromolecules (2024) Vol. 280, pp. 136058-136058
Closed Access | Times Cited: 2

Unlocking the Potential of Camel Milk-Derived Exosomes as Novel Delivery Systems: Enhanced Bioavailability of ARV-825 PROTAC for Cancer Therapy
Aakash Nathani, Mounika Aare, Li Sun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1070-1070
Open Access | Times Cited: 1

cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer
Farah Benyettou, Mostafa Khair, Thirumurugan Prakasam, et al.
ACS Applied Materials & Interfaces (2024)
Open Access | Times Cited: 1

Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer
Hardik Patni, Ramesh Chaudhary, Ashutosh Kumar
Nanoscale (2024)
Closed Access | Times Cited: 1

Page 1

Scroll to top